Journal of Clinical Endocrinology & Metabolism

Papers
(The H4-Index of Journal of Clinical Endocrinology & Metabolism is 55. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico277
Subacute Thyroiditis After Sars-COV-2 Infection252
Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function222
Update on PCOS: Consequences, Challenges, and Guiding Treatment206
Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection182
Thyroid Dysfunction in Relation to Immune Profile, Disease Status, and Outcome in 191 Patients with COVID-19163
The Menopause Transition: Signs, Symptoms, and Management Options145
Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine: Postvaccination ASIA Syndrome137
Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists134
Thyroid Function Before, During, and After COVID-19132
Contemporary Thyroid Nodule Evaluation and Management130
International Histopathology Consensus for Unilateral Primary Aldosteronism126
Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes126
Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS118
Management of Graves Thyroidal and Extrathyroidal Disease: An Update100
Hypoparathyroidism99
Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment99
Is Subacute Thyroiditis an Underestimated Manifestation of SARS-CoV-2 Infection? Insights From a Case Series98
GIP as a Therapeutic Target in Diabetes and Obesity: Insight From Incretin Co-agonists97
Racial-Ethnic Inequity in Young Adults With Type 1 Diabetes95
Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals87
Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline86
Moderate-Intensity Exercise and High-Intensity Interval Training Affect Insulin Sensitivity Similarly in Obese Adults85
Intermittent Fasting Improves Cardiometabolic Risk Factors and Alters Gut Microbiota in Metabolic Syndrome Patients84
Prognostic and Therapeutic Role of Vitamin D in COVID-19: Systematic Review and Meta-analysis83
Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations81
The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD81
Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China80
Very-Low-Calorie Ketogenic Diets With Whey, Vegetable, or Animal Protein in Patients With Obesity: A Randomized Pilot Study79
Ketone Body, 3-Hydroxybutyrate: Minor Metabolite - Major Medical Manifestations77
Early Prediction of Gestational Diabetes Mellitus in the Chinese Population via Advanced Machine Learning76
Gut Dysbiosis Contributes to the Imbalance of Treg and Th17 Cells in Graves’ Disease Patients by Propionic Acid75
Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis72
Genetic Support of A Causal Relationship Between Iron Status and Type 2 Diabetes: A Mendelian Randomization Study70
The Integration of Sex and Gender Considerations Into Biomedical Research: Lessons From International Funding Agencies68
New Horizons: Novel Approaches to Enhance Healthspan Through Targeting Cellular Senescence and Related Aging Mechanisms67
Evolution of the Primary Aldosteronism Syndrome: Updating the Approach66
Dysnatremia is a Predictor for Morbidity and Mortality in Hospitalized Patients with COVID-1965
Approach to the Patient with MODY-Monogenic Diabetes64
Health Care-Related Economic Burden of Polycystic Ovary Syndrome in the United States: Pregnancy-Related and Long-Term Health Consequences64
Association Between Midlife Obesity and Its Metabolic Consequences, Cerebrovascular Disease, and Cognitive Decline63
Effect of Diet on Insulin Resistance in Polycystic Ovary Syndrome63
A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic63
Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline62
Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome61
Non-invasive Diagnostic Strategy in ACTH-dependent Cushing’s Syndrome60
Radiological Thoracic Vertebral Fractures are Highly Prevalent in COVID-19 and Predict Disease Outcomes60
Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring60
Metabolic Effects of Late Dinner in Healthy Volunteers—A Randomized Crossover Clinical Trial59
The Association of Gut Microbiota With Osteoporosis Is Mediated by Amino Acid Metabolism: Multiomics in a Large Cohort58
MicroRNA-15b Targets VEGF and Inhibits Angiogenesis in Proliferative Diabetic Retinopathy58
Vitamin D Status and Risk of All-Cause and Cause-Specific Mortality in a Large Cohort: Results From the UK Biobank58
VITamin D and OmegA-3 TriaL (VITAL): Effects of Vitamin D Supplements on Risk of Falls in the US Population57
Casting a Health Equity Lens on Endocrinology and Diabetes56
Effect of Vitamin D Supplementation on the Incidence of Diabetes Mellitus56
Inequities in Diabetic Ketoacidosis Among Patients With Type 1 Diabetes and COVID-19: Data From 52 US Clinical Centers55
Calcifediol Treatment and COVID-19–Related Outcomes55
0.02824592590332